DrugPatentWatch Database Preview
Patent: 6,057,156
» See Plans and Pricing
Summary for Patent: 6,057,156
| Title: | Enzymatic nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptors |
| Abstract: | Enzymatic nucleic acid molecules which cleave EGFR RNA. |
| Inventor(s): | Akhtar; Saghir (Birmingham, GB), Fell; Patricia (Wythall, GB), McSwiggen; James A. (Boulder, CO) |
| Assignee: | Robozyme Pharmaceuticals, Inc. (Boulder, CO) |
| Application Number: | 08/985,162 |
| Patent Claims: | see list of patent claims |
Details for Patent 6,057,156
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 003 | 1986-06-04 | Start Trial | Robozyme Pharmaceuticals, Inc. (Boulder, CO) | 2017-01-31 | RX | search | |
| Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 002 | 1986-06-04 | Start Trial | Robozyme Pharmaceuticals, Inc. (Boulder, CO) | 2017-01-31 | RX | search | |
| Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | Robozyme Pharmaceuticals, Inc. (Boulder, CO) | 2017-01-31 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 6,057,156
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| United States of America | 2001006801 | Start Trial |
| United States of America | 2002013458 | Start Trial |
| United States of America | 2002082225 | Start Trial |
| United States of America | 2002192685 | Start Trial |
| United States of America | 2002193579 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
